Braze price target lowered to $35 from $68 at Citizens

Citizens lowered the firm’s price target on Braze (BRZE) to $35 from $68 and keeps an Outperform rating on the shares. Braze reported strong Q4 results with accelerating 28% revenue growth, expanding margins, and CRPO above expectations, driving the stock up about 20% after a 45% year-to-date decline, though mixed guidance prompts the price target reduction, the analyst tells investors in a research note. Despite AI-related competitive concerns, improving fundamentals, rising net revenue retention, and strategic appeal to larger platforms such as Salesforce (CRM), Adobe (ADBE), SAP (SAP), or Microsoft (MSFT) support a constructive long-term view, the firm says.